Concepedia

Publication | Closed Access

Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response

DOI

163

Citations

16

References

2016

Year

Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Renee Vermeij, Linda F. M. Stynenbosch, Nikki M. Loof, Dorien M. A. Berends-van der Meer, Margriet J. Löwik, Ineke L.E. Hamming, Edith M.G. van Esch, Bart W.J. Hellebrekers,
Clinical Cancer Research

Abstract

This new study confirms that clinical efficacy of ISA101 vaccination is related to the strength of vaccine-induced HPV16-specific T-cell immunity and is an effective therapy for HPV16-induced high-grade VIN/VaIN. Clin Cancer Res; 22(10); 2342-50. ©2016 AACRSee related commentary by Karaki et al., p. 2317.

References

YearCitations

Page 1